Iron oxide magnetic resonance imaging for atherosclerosis therapeutic evaluation: still "rusty?".
Fayad
Zahi A
ZA
Razzouk
Louai
L
Briley-Saebo
Karen C
KC
Mani
Venkatesh
V
D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000069059:Atorvastatin; D015415:Biomarkers; D016893:Carotid Stenosis / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D005290:Ferric Compounds; D006538:Heptanoic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007249:Inflammation / Q000175:diagnosis / Q000188:drug therapy; D008264:Macrophages / Q000187:drug effects*; D053758:Nanoparticles; D011758:Pyrroles / Q000008:administration & dosage / Q000627:therapeutic use*
D000924:Anticholesteremic Agents; D015415:Biomarkers; D005290:Ferric Compounds; D006538:Heptanoic Acids; D011758:Pyrroles; C000499:ferric oxide; D000069059:Atorvastatin